AU2006301578B9 - Method for diagnosing thromboembolic disorders and coronary heart diseases - Google Patents
Method for diagnosing thromboembolic disorders and coronary heart diseases Download PDFInfo
- Publication number
- AU2006301578B9 AU2006301578B9 AU2006301578A AU2006301578A AU2006301578B9 AU 2006301578 B9 AU2006301578 B9 AU 2006301578B9 AU 2006301578 A AU2006301578 A AU 2006301578A AU 2006301578 A AU2006301578 A AU 2006301578A AU 2006301578 B9 AU2006301578 B9 AU 2006301578B9
- Authority
- AU
- Australia
- Prior art keywords
- group
- coronary heart
- egln2
- determined
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn - After Issue
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005048899.4 | 2005-10-12 | ||
| DE102005048899A DE102005048899A1 (de) | 2005-10-12 | 2005-10-12 | Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen |
| PCT/EP2006/009517 WO2007042165A1 (de) | 2005-10-12 | 2006-09-30 | Verfahren zur diagnose thromboembolischer erkrankungen und koronarer herzerkrankungen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2006301578A1 AU2006301578A1 (en) | 2007-04-19 |
| AU2006301578B2 AU2006301578B2 (en) | 2011-12-01 |
| AU2006301578B9 true AU2006301578B9 (en) | 2011-12-22 |
Family
ID=37684083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2006301578A Withdrawn - After Issue AU2006301578B9 (en) | 2005-10-12 | 2006-09-30 | Method for diagnosing thromboembolic disorders and coronary heart diseases |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20090197774A1 (OSRAM) |
| EP (1) | EP1937839B1 (OSRAM) |
| JP (1) | JP2009511026A (OSRAM) |
| KR (1) | KR20080052662A (OSRAM) |
| CN (1) | CN101287846A (OSRAM) |
| AR (1) | AR056125A1 (OSRAM) |
| AT (1) | ATE525481T1 (OSRAM) |
| AU (1) | AU2006301578B9 (OSRAM) |
| BR (1) | BRPI0617341A2 (OSRAM) |
| CA (1) | CA2625698A1 (OSRAM) |
| DE (1) | DE102005048899A1 (OSRAM) |
| IL (1) | IL190585A (OSRAM) |
| TW (1) | TW200734638A (OSRAM) |
| WO (1) | WO2007042165A1 (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005048898A1 (de) * | 2005-10-12 | 2007-04-19 | Sanofi-Aventis Deutschland Gmbh | EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen |
| EP2311981B1 (en) | 2007-05-01 | 2014-09-17 | The Regents of The University of California | Methods for diagnosing ischemia |
| EP2593566B1 (en) | 2010-07-14 | 2018-01-24 | The Regents of The University of California | Biomarkers for diagnosis of transient ischemic attacks |
| CA2804802C (en) | 2010-07-15 | 2023-03-07 | The Regents Of The University Of California | Biomarkers for diagnosis of stroke and its causes |
| US20120316076A1 (en) | 2011-03-04 | 2012-12-13 | The Regents Of The University Of California | Biomarkers for the diagnosis of lacunar stroke |
| CN104094121B (zh) | 2011-12-01 | 2016-10-26 | 霍夫曼-拉罗奇有限公司 | 用于诊断中风的nt-原anp和nt-原bnp |
| WO2013103781A1 (en) | 2012-01-07 | 2013-07-11 | The Regents Of The University Of California | Biomarkers for diagnosing ischemia |
| KR101939778B1 (ko) | 2012-07-27 | 2019-01-18 | 삼성전자주식회사 | 필요 혈류량 결정 방법 및 장치, 혈류 영상 생성 방법 및 장치, 심근 관류 영상 처리 방법 및 장치 |
| CN119846215B (zh) * | 2025-01-22 | 2025-07-11 | 广西医科大学附属肿瘤医院 | Egln1乳酸化作为靶点在制备肿瘤诊断试剂盒或治疗药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7482117B2 (en) * | 2002-12-20 | 2009-01-27 | Celera Corporation | Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| US7306913B2 (en) * | 2002-12-20 | 2007-12-11 | Applera Corporation | Genetic polymorphisms associated with coronary stenosis, methods of detection and uses thereof |
-
2005
- 2005-10-12 DE DE102005048899A patent/DE102005048899A1/de not_active Withdrawn
-
2006
- 2006-09-30 AT AT06792341T patent/ATE525481T1/de active
- 2006-09-30 CA CA002625698A patent/CA2625698A1/en not_active Withdrawn
- 2006-09-30 JP JP2008534895A patent/JP2009511026A/ja not_active Abandoned
- 2006-09-30 EP EP06792341A patent/EP1937839B1/de not_active Not-in-force
- 2006-09-30 CN CNA2006800376009A patent/CN101287846A/zh active Pending
- 2006-09-30 WO PCT/EP2006/009517 patent/WO2007042165A1/de not_active Ceased
- 2006-09-30 KR KR1020087008790A patent/KR20080052662A/ko not_active Withdrawn
- 2006-09-30 AU AU2006301578A patent/AU2006301578B9/en not_active Withdrawn - After Issue
- 2006-09-30 BR BRPI0617341-1A patent/BRPI0617341A2/pt not_active Application Discontinuation
- 2006-09-30 US US12/089,624 patent/US20090197774A1/en not_active Abandoned
- 2006-10-05 TW TW095136992A patent/TW200734638A/zh unknown
- 2006-10-10 AR ARP060104446A patent/AR056125A1/es unknown
-
2008
- 2008-04-02 IL IL190585A patent/IL190585A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0617341A2 (pt) | 2011-07-26 |
| EP1937839A1 (de) | 2008-07-02 |
| JP2009511026A (ja) | 2009-03-19 |
| DE102005048899A1 (de) | 2007-04-19 |
| IL190585A (en) | 2011-12-29 |
| TW200734638A (en) | 2007-09-16 |
| WO2007042165A1 (de) | 2007-04-19 |
| US20090197774A1 (en) | 2009-08-06 |
| AU2006301578A1 (en) | 2007-04-19 |
| CA2625698A1 (en) | 2007-04-19 |
| AR056125A1 (es) | 2007-09-19 |
| ATE525481T1 (de) | 2011-10-15 |
| EP1937839B1 (de) | 2011-09-21 |
| IL190585A0 (en) | 2008-11-03 |
| KR20080052662A (ko) | 2008-06-11 |
| CN101287846A (zh) | 2008-10-15 |
| AU2006301578B2 (en) | 2011-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12065702B2 (en) | Mitochondrial markers of neurodegenerative diseases | |
| IL190585A (en) | Method for the diagnosis of thromboembolic and coronary heart diseases | |
| JP4516990B2 (ja) | ワルファリンの投与量の範囲を予想する方法 | |
| WO2001053537A2 (en) | Nitric oxide synthase gene diagnostic polymorphisms | |
| CA2675606A1 (en) | Diagnostic marker and platform for drug design in myocardial infarction and heart failure | |
| CN100549173C (zh) | 具有特定单核苷酸多态性的th基因及其检测方法和用途 | |
| EP1960543B1 (en) | Method for the diagnosis and treatment of cardiovascular diseases | |
| US9909182B1 (en) | Methods for identifying subjects susceptible to charcot-marie-tooth neuropathy type 1C | |
| JP3682688B2 (ja) | 骨粗鬆症薬剤感受性予測方法およびそのための試薬キット | |
| JP4444576B2 (ja) | ２型糖尿病関連遺伝子 | |
| CN102443630A (zh) | 人ppp2r3a基因突变及其用途 | |
| JP2003245087A (ja) | 遺伝子診断方法 | |
| HK1125414A (en) | Method for diagnosing thromboembolic disorders and coronary heart diseases | |
| JP4845486B2 (ja) | 糖尿病性腎症感受性遺伝子、および糖尿病性腎症の予防または治療剤の有効成分のスクリーニング方法 | |
| JP4048555B2 (ja) | 骨粗鬆症薬剤感受性予測方法 | |
| JP5235448B2 (ja) | 糖尿病性腎症感受性遺伝子、および糖尿病性腎症の予防または治療剤の有効成分のスクリーニング方法 | |
| JP3684921B2 (ja) | 骨粗鬆症薬剤感受性予測方法 | |
| Khin Sandar | Association Between Angiotensinogen Gene M235T Polymorphism and Plasma Angiotensinogen Level in Essential Hypertension | |
| WO2006073183A1 (ja) | 一塩基多型を用いた炎症性疾患の判定方法 | |
| JPWO2006068111A1 (ja) | ＰＰＡＲγ遺伝子の遺伝子多型に関連する表現型の判定方法 | |
| WO2002006522A2 (en) | Estrogen receptor gene polymorphisms as markers for determining a predisposition for low bone density | |
| NZ564717A (en) | Marker assisted selection of bovine for desired milk fat colour |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SREP | Specification republished | ||
| MK12 | Application lapsed section 141(1)/reg 8.3(2) - applicant filed a written notice of withdrawal |